Skin Analytics raises £15m in Series B funding led by Intrepid Growth Partners to expand its AI dermatology technology globally.
The Series B round was led by Intrepid Growth Partners and will support international expansion and product development.
Skin Analytics is a British healthtech company that develops autonomous AI medical devices for skin cancer detection. Its technology is deployed across multiple NHS sites to triage referrals and alleviate specialist shortages.
Skin Analytics has secured £15m in Series B funding to accelerate its international expansion and broaden its dermatology product range. The round was led by specialist AI investor Intrepid Growth Partners.
The capital will support the company as it scales its operations into the US market and other key regions facing acute shortages of dermatologists. Skin Analytics has already established a significant presence in the UK, where its DERM software is deployed across numerous NHS sites to process urgent referrals and ease pressure on healthcare systems.
Following recent regulatory approval for its Class III CE mark in the EU, the firm aims to deploy its technology globally. The funding will also be directed towards recruiting top-tier talent in artificial intelligence and healthcare to support its continued growth.
From the founder
"This is just the beginning. AI will allow us to redesign healthcare systems around the world to the benefit of patients. The faster we scale, the more lives we can impact. That mission drives us every day."
Neil Daly
Founder and CEO at Skin Analytics
Investor perspective
"At Intrepid Growth Partners, we invest in transformative machine intelligence-driven solutions that address critical challenges, and Skin Analytics exemplifies this vision. Their technology is redefining early skin cancer detection, improving patient outcomes while reducing healthcare costs. We are excited to support their growth as they scale their impact globally."
Mark Machin
Co-founder & Managing Partner, Intrepid Growth Partners
Use of funds
- 01Continue product development
- 02Expand into international markets
- 03Grow the team
Investors
Categories
About the company
Skin Analytics
Skin Analytics develops autonomous AI medical devices for skin cancer detection.